NVUS News and Press, Novus Therapeutics Inc. From 09/17/20

Strongbridge Biopharma (NASDAQ: SBBP )   -16%  after pricing $25M share offering. More news on: Strongbridge Biopharma plc, NuCana plc, Dave & Buster's Entertainment, Inc., Stocks on the move, , Read more ...

Gainers:  Arrowhead Pharmaceuticals (NASDAQ: ARWR ) +47% . More news on: Arrowhead Pharmaceuticals, Inc., Eastman Kodak Company, Myomo, Inc., Stocks on the move, , Read more ...

Novus Therapeutics (NASDAQ: NVUS ) -17% . More news on: Novus Therapeutics, Inc., Nano-X Imaging Ltd., Plus Therapeutics, Inc., Stocks on the move, , Read more ...

Novus Therapeutics, Inc. (“Novus”) (NASDAQ: NVUS), a clinical stage biotechnology company targeting the CD40L pathway to develop potential treatments for organ or cell-based transplant, autoimmune and neurodegenerative diseases, today announced that David-Alexandre C. Gros, M.D....

Novus Therapeutics, Inc. (NVUS) Novus Therapeutics Announces Acquisition of Anelixis Therapeutics September 15, 2020 08:30 AM ET Company Participants Jon Kuwahara - SVP, Finance & Administration Keith Katkin - Chairman of the Board of Directors of Novus Therapeutics Dr. David...

Gainers: Novus Therapeutics (NASDAQ: NVUS ) +162% . More news on: Novus Therapeutics, Inc., Marinus Pharmaceuticals, Inc., Plus Therapeutics, Inc., Stocks on the move, , Read more ...

Penny Stocks Under $1 To Watch Today Penny Stocks are some of the most widely sought after equity classes among day traders. The fact that you can spend a small sum in return for larger percentage gains is a unique phenomenon. While blue chip stocks like Apple, Amazon, General Motors, and ...

List Of Penny Stocks Making Aftermarket Moves On Monday Are you putting together a list of penny stocks for Tuesday? If you said yes, you’re not alone. There are plenty of traders looking to gain the edge when it comes to “getting in early”. Getting at the lowest low and...

Acquisition includes lead clinical-stage compound AT-1501, a next generation anti-CD40L antibody, in development for organ and cellular transplantation, autoimmune diseases, and neurodegenerative diseases Senior management team with extensive drug development and commercialization expe...

Gainers: Cemtrex (NASDAQ: CETX )  +209% . More news on: Cemtrex, Inc., Digital Ally, Inc., Allied Esports Entertainment Inc., Stocks on the move, , Read more ...